INTRODUCTION
The anaerobic bacterium Clostridium difficile is a major human nosocomial pathogen, the most commonly diagnosed cause of infectious hospital diarrhoea (Riley, 1998) . In humans C. difficile infection (CDI) has a wide clinical spectrum, ranging from asymptomatic carriage, to mild-selflimiting diarrhoea, and more severe pseudomembranous colitis. Toxigenic isolates of C. difficile usually produce two toxins, toxin A and toxin B, and these are thought of as the major virulence factors. Some strains of C. difficile produce an additional toxin, binary toxin (actin-specific ADP-ribosyltransferase, CDT), first reported in 1988 but not considered important until now (Riley, 2006) . In both North America and Europe, a hypervirulent strain of C. difficile (PCR ribotype 027) has appeared in the last few years resulting in high mortality and morbidity in humans. This strain is resistant to fluoroquinolone antibiotics, and use of fluoroquinolones appears to be driving the epidemic (Riley, 2006) . In an epidemic in Canada, on average, each case resulted in an additional 10.7 days in hospital and, compared with controls, patients with CDI had a significantly higher mortality of .10 % in those aged 70 years or more (Loo et al., 2005) .
There has been speculation that C. difficile may be zoonotic and that transmission of infection via spores may be food borne (Rupnik, 2007) . C. difficile is known to colonize many animals (Levett, 1986) . Indeed, as with humans, the gastrointestinal tracts of most infant animals are probably colonized by C. difficile until weaning. In the last 20 years, C. difficile has become accepted as an enteric pathogen in horses, particularly in Europe (Båverud, 2004) and North America (Weese et al., 2001) but not universally in Australia. The bacterium is associated with acute colitis in mature horses usually following treatment with antibiotics (Båverud et al., 1997; Ruby et al., 2009) . C. difficile, and/or its cytotoxin, is also associated with acute colitis in mares when their foals are being treated with erythromycin and rifampicin for Rhodococcus equi pneumonia (Båverud et al., 1998) . C. difficile can be isolated from foals with diarrhoea (Jones et al., 1987) , although foals under the age of 2 weeks are often colonized with C. difficile with no apparent disease (Båverud et al., 2003) .
There are no data on C. difficile disease in horses in Australia. This paper presents a preliminary investigation into the prevalence of C. difficile in horses with and without diarrhoea in Australia. In addition to determining prevalence, a further objective was to determine the production of toxins by and the antibiotic susceptibility patterns of any strains isolated. (Bowman & Riley, 1988) . In addition to solid media, an enrichment broth containing gentamicin, cycloserine and cefoxitin (GCC broth) was employed as described previously (Carroll et al., 1983) . Environmental samples were cultured in and on media containing sodium taurocholate, as this has been shown to enhance germination of C. difficile spores. Putative colonies of C. difficile were confirmed by their characteristic appearance and odour, followed by a specific latex particle agglutination (Bowman et al., 1986) . Isolates were confirmed as C. difficile by a species-specific PCR that also identified the presence of toxin A (tcdA), toxin B (tcdB) and binary toxin genes (cdtA and cdtB). Antimicrobial susceptibility patterns were determined by agar dilution and Etest strip (bioMérieux).
Typing of isolates. For accurately determining the epidemiology of infection it is necessary to type isolates from animals and the environment to show how they are related. Although a variety of different typing methods have been developed for C. difficile (Brazier, 2001) , PCR ribotyping (Stubbs et al., 1999) has gained widespread acceptance as the method of choice in Europe and continues to be applied throughout the world. This technique was applied to all isolates to look for relatedness and clusters.
Risk factors. When available, data were collected on antibiotic exposure and other potential risk factors for C. difficile.
RESULTS AND DISCUSSION
The overall prevalence of C. difficile in the diarrhoeal horses studied was 23 % (14/62). C. difficile was found only in this group, and in none of 112 normal healthy adult horses (82 from Western Australia and 30 from New South Wales). In relation to the horses (adults and foals) with diarrhoea, of the 5 (11 %) positive samples from 47 samples from Western Australia, 3 were from adults and 2 were from foals aged 5 and 6 months, while of the 9 (60 %) positive samples from 15 samples from New South Wales, 1 was an adult and 8 were foals. All New South Wales foals were less than 2 weeks old and seven of the nine positive horses in New South Wales had been given antibiotics. A total of 43 environmental swabs was taken from surfaces in the Murdoch University veterinary clinic equine section (treatment areas/ isolation areas) and none was positive for C. difficile. . There were six different ribotypes detected, ribotype 012 being the most common with six isolates. Two horses (one adult and one foal) had two different strains of C. difficile isolated on different days. These strains had the same toxin profile but were different ribotypes. The most common PCR ribotype recovered was PCR ribotype 012, which comprised 6 of the 16 isolates (37.5 %). The only other ribotype identified with more than 1 isolate was PCR ribotype 014 with 2 of 16 (12.5 %).
Antibiotic susceptibility data for the 16 isolates of C. difficile are given in Table 1 . There was no vancomycin or metronidazole resistance detected, with MICs generally extremely low for both antimicrobials. In addition, there was no high level (MICs .128 mg l
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) resistance to clindamycin. Three strains showed high-level resistance to levofloxacin, two of which were also resistant to moxifloxacin. One strain showed resistance to penicillin, and this requires further investigation, while several strains showed borderline resistance to this drug.
There are a number of causes of diarrhoea in the horse, both infectious and non-infectious. The infectious agents most commonly isolated from horses with colitis are C. difficile, Clostridium perfringens and Salmonella spp. (Weese et al., 2001; Weese, 2002) . Horses also get colitis following antibiotic therapy, 'antibiotic-associated diarrhoea' and, as with humans, this is often associated with C. difficile (Madewell et al., 1995; Weese et al., 2001; Ruby et al., 2009) . Despite this mounting evidence, there has been some scepticism in Australian equine circles about any role that C. difficile might play in colitis in horses. This is perhaps not surprising as a role for C. difficile in diarrhoeal disease in horses is only a relatively recent finding. Indeed, the epidemiology of CDI in production and companion animals has changed rapidly over the last 10-20 years. Whereas C. difficile was never thought of as a pathogen or colonizer of pigs, cows or turkeys in the past, a recently published survey of retail pork, beef and turkey in the USA indicated that 40 % of samples were contaminated with C. difficile (Songer et al., 2009b) . In addition, C. difficile causes clinical disease in neonatal piglets and is now the leading cause of neonatal scours in these animals, resulting in considerable morbidity and mortality, and subsequent economic losses for the industry (Songer et al., 2000) . In companion animals the situation was a little different with 40 % of animals attending a veterinary clinic in Perth, Western Australia, in the early 1990s colonized with C. difficile. However, these strains did not appear to be infecting humans (Riley et al., 1991) . Today the situation is different, and human infection, apparently with animal strains of C. difficile, is common in Europe (Goorhuis et al., 2008) .
This project represents the first survey of its kind in Australia. Even though the number of samples was limited, and the EI outbreak in 2007-2008 impacted on the availability of samples, the results are nonetheless very revealing. There is now no doubt that C. difficile can be found in Australian horses and is apparently associated with diarrhoeal disease, although further better controlled studies will be required to document its exact role. In the present study, it was not possible to culture all diarrhoeal samples for other enteric pathogens, and information on whether this had been done elsewhere was not always available.
However, the overall isolation rate for C. difficile in diarrhoeal horses was 23 %, which compares favourably with the publication by Båverud (2004) in which the prevalence was 42 % in horses with acute colitis during antibiotic treatment. C. difficile may also have a role in other gastrointestinal diseases in horses. Arroyo et al. (2006) recently reported C. difficile as a possible cause of duodenitis-proximal jejunitis in horses, and colitis X in horses has been associated with the isolation of C. difficile (Songer et al., 2009a) . The role of C. difficile in disease in foals in the absence of antimicrobial exposure is less clear. There are several reports of CDI in foals but the picture is different to adult horses with diarrhoea in the absence of antibiotic therapy (Magdesian et al., 2002) . This is not unique to horses. C. difficile can also be isolated from calves with and without diarrhoea with equal frequency (Rodriguez-Palacios et al., 2006) . It is likely that all young animals are colonized with C. difficile from birth. Once a more adult gastrointestinal microflora is established then C. difficile cannot compete and is eliminated. However, it is still possible that C. difficile causes disease in young animals, with piglets being the prime example.
None of 43 environmental swabs taken from surfaces in the Murdoch University equine section (treatment areas/ isolation areas) was positive for C. difficile. This was a little surprising given the widespread environmental contamination that occurs with C. difficile in the veterinary setting (Weese et al., 2000; Båverud et al., 2003) ; however, what number of horses had been through the facility and how much cleaning had occurred afterwards was not known. Certainly the facility looked very clean to the naked eye.
The ribotypes of C. difficile recovered from horses in this study were very similar to those isolated from humans in Australia (B. Elliott and T. V. Riley, unpublished data). Ribotype 014 is the most common ribotype (17 %) of C. difficile isolated from humans in Australia, while ribotype 012 is also quite common. The sharing of ribotypes between horses and humans has been reported before and indeed appears quite common (Keel et al., 2007) . This is different to the situation with cattle/pigs and humans where, until recently, most cattle/pig isolates of C. difficile were ribotype 078, a type rarely found in humans previously. This has now changed with ribotype 078, apparently from pigs, now a common ribotype of C. difficile isolated from humans in Europe (Goorhuis et al., 2008; Bauer et al., 2011) . Clearly the possibility of the transfer of animal strains of C. difficile to humans exists, as does the reverse, and this should be a cause for concern by anyone involved in production/companion animal industries.
Most strains of C. difficile isolated in this study remained susceptible to the majority of antibiotics. One cause for concern was the two isolates (12.5 %) that were resistant to moxifloxacin. Fluoroquinolone resistance in certain strains of C. difficile and overuse of fluoroquinolones is driving the current human C. difficile epidemic overseas. C. difficile quickly mutates to a state of fluoroquinolone resistance after exposure to this group of antibiotics through changes to the gyrA and gyrB genes (Ackermann et al., 2003) . No metronidazole resistance was seen, in contrast to some reports in both humans (Peláez et al., 2002) and horses (Magdesian et al., 2002) .
It may also be worth mentioning that there has been little evaluation of the methods for detecting C. difficile in horse faecal samples. A number of enzyme immunoassay kits are marketed for this purpose in humans; however, these have not been evaluated extensively in horses (Medina-Torres et al., 2010) . In the present study, samples from 10 of the 14 horses from which C. difficile was isolated were evaluated with the C. diff Quik Chek Complete kit (TechLab). Nine of the ten were positive for the GDH component of the kit while only one gave a positive for the toxinA/B component of the kit (S. Thean & T. V. Riley, data not shown). Many human diagnostic laboratories are moving to molecular methods with either in-house or commercially available tests to detect mainly the toxin B gene in C. difficile. Again there has been little molecular diagnostic work with horses and this may be a fruitful avenue for research in the future.
In summary, C. difficile is present in Australian adult horses and foals with diarrhoea. What role the organism plays, particularly in diarrhoea in foals, requires further investigation. However, the evidence from this study and the literature suggests C. difficile may be an important cause of diarrhoea in adult horses and the industry should not ignore this.
